OTC - ACTIVE INGREDIENT SECTION
Active ingredients:
Salicylic Acid 2.0%
Purpose: Acne Treatment Serum
Active ingredients:
Salicylic Acid 2.0%
Purpose: Acne Treatment Serum
Uses: For management of acne
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Stop use and consult a doctor if irritation continues.
Warning:
Directions:
Inactive Ingredients: Water, Butylene Glycol, Propanediol, Pentylene Glycol, 1,2-Hexanediol, Sodium Polyacryloyldimethyl Taurate Octyldodecanol, Glycerin, Hydroxyacetophenone, Pyrus Malus (Apple) Fruit Extract, Sodium Hydroxide, Beta Vulgaris (Beet) Root Extract, Fructooligosaccharides, Hydroxyethylcellulose, Tetrahexyldecyl Ascorbate, Tetrasodium Glutamate Diacetate, Leptospermum Scoparium Branch/Leaf Oil, Aloe Barbadensis Leaf Juice, Magnolia Officinalis Bark Extract, Piper Nigrum (Pepper) Seed Extract, Phragmites Communis Extract, Poria Cocos Extract
DIME
ACNE TONING SERUM
SALICYLIC ACID + MAGNOLIA BARK
2 OZ 60 ML
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82870-003-01 | Acne Toner Serum | 60 mL in 1 BOTTLE | CREAM | 60 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 82870-003 | 82870-003-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acne Toner Serum | SALICYLIC ACID | Dime Beauty Co, LLC | e5c35684-e8b5-70fd-e053-2a95a90aedae | 2025-10-01 | Warnings | 82870-003-01 82870-003 82870000301 401d2f24-ceca-c81b-e063-6394a90a11df e5c35684-e8b5-70fd-e053-2a95a90aedae |
Adverse event summaries are temporarily unavailable. Other product information remains available.